Bridgeway Capital Management’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
LP
Bridgeway Capital Management's AGN Position: Q1 2019 in Review
Bridgeway Capital Management sold out of Allergan plc (AGN) in Q1 2019, closing a stake of 307,765 shares — an estimated $41.1M sold.
Bridgeway Capital Management first reported a position in AGN in Q4 2013 and held it in 17 quarters. The position peaked at $58.6M in Q3 2018. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.
- Bridgeway Capital Management reported no remaining Allergan plc position as of Q1 2019 after selling out during the quarter.
- Bridgeway Capital Management sold 307,765 Allergan plc shares in Q1 2019, an estimated $41.1M.
- Bridgeway Capital Management first reported a position in Allergan plc in Q4 2013 and held it in 17 quarters.
- Bridgeway Capital Management's Allergan plc position peaked at $58.6M in Q3 2018.
- 991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.
Based on Bridgeway Capital Management's 13F filing for Q1 2019, filed 15 May 2019.